Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Robitussin for Quality of Life in Common Cold
NCT06716645Phase 4Completed
- Sponsor
- Haleon
- Start
- Dec 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dextromethorphan in common cold and cough, sponsored by Haleon. Primary endpoints: Wisconsin Upper Respiratory Symptom Survey-21 Total at 7 days, Wisconsin Upper Respiratory Symptom Survey-21 Total Symptom Domain at 7 days and 8 more. Started Dec 2024; status: completed.
02
Drugs
dextromethorphan
03
Conditions
common coldcough
Beyond the preview
Go deeper on NCT06716645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06716645.